Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.40
0.78 (16.88%)
At close: Jun 27, 2025, 3:59 PM
5.97
10.56%
After-hours: Jun 27, 2025, 05:55 PM EDT
16.88% (1D)
| Bid | 5.54 |
| Market Cap | 193.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -26.22M |
| EPS (ttm) | -0.76 |
| PE Ratio (ttm) | -7.11 |
| Forward PE | -5.23 |
| Analyst | Buy |
| Ask | 6 |
| Volume | 25,778 |
| Avg. Volume (20D) | 12,935 |
| Open | 4.68 |
| Previous Close | 4.62 |
| Day's Range | 4.67 - 5.47 |
| 52-Week Range | 2.20 - 5.47 |
| Beta | 1.43 |
About EPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+10.37%
Eupraxia Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
7 months ago
+10.43%
Eupraxia Pharmaceuticals shares are trading higher after the company unveiled new pharmacokinetic data from its Phase 2A eosinophilic esophagitis program.